Products
Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-INN-810
Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Efaprinermin Alfa contains tumor necrosis factor superfamily protein TNFSF18 (human) trimer fusion protein with immunoglobulin g1 (human fc fragment). It is used for the high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers.
Order information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
| Catalog No. | Package | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| GMP-Bios-INN-810-1mg | 1mg | 3090 | ||
| GMP-Bios-INN-810-10mg | 10mg | Inquiry | ||
| GMP-Bios-INN-810-100mg | 100mg | Inquiry | ||
| GMP-Bios-INN-810-xmg | ≥100mg | Inquiry | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| Products Name (INN Index) | Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D |
| INN Name | Efaprinermin Alfa |
| Target | TNFRSF18 |
| Format | Fusion Protein |
| Derivation | human |
| Species Reactivity | human |
| CH1 Isotype | Fusion - [TNFSF18 (TNF superfamily member 18, AITRL, TL6, GITRL)]2 - IGHG1 Fc (Fragment constant) |
| VD LC | Fusion - [TNFSF18 (TNF superfamily member 18, AITRL, TL6, GITRL)]2 - IGHG1 Fc (Fragment constant) |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | OncoMed Pharmaceuticals (Redwood City CA USA) |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | 0 |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
Facebook
LinkedIn
Twitter
